Andreas E Kremer

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Replacement Therapy

Gold Nanoparticles

Ulcerative Colitis

Ejection Fraction

Top Venues

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

David E J Jones, Ulrich H W Beuers, Alan Bonder, Marco Carbone, Emma L Culver, Jessica Katharine Dyson, Robert G Gish, Bettina E Hansen, Gideon M Hirschfield, Rebecca Jones, Kris Kowdley, Andreas E Kremer, Keith D Lindor, Marlyn J Mayo, George Mells, James Neuberger, Martin Prince, Mark G Swain, Atsushi Tanaka, Douglas Thorburn, Michael Trauner, Palak J Trivedi, Martin Weltman, Andrew D Yeoman, Cynthia Levy
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here? Hepatology (Baltimore, Md.) (2024)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces interleukin-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) (2023)
Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, Cynthia Levy, Christopher L Bowlus, David E Jones, Jeff D Johnson, Charles A McWherter, Yun-Jung Choi
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. Hepatology (Baltimore, Md.) 80 (1) (2023)
Gideon M Hirschfield, Mitchell L Shiffman, Gideon M Hirschfield, Kris V Kowdley, John M Vierling, Cynthia Levy, Andreas E Kremer, Ehud Zigmond, Pietro Andreone, Stuart C Gordon, Christopher L Bowlus, Eric J Lawitz, Richard J Aspinall, Daniel S Pratt, Karina Raikhelson, Maria S Gonzalez-Huezo, Michael A Heneghan, Sook-Hyang Jeong, Alma L Ladrón de Guevara, Marlyn J Mayo, Georgios N Dalekos, Joost Paulus Hubertus Drenth, Ewa Janczewska, Barbara A Leggett, Frederik Nevens, Víctor Vargas, Eli Zuckerman, Christophe Corpechot, Eduardo Fassio, Holger Hinrichsen, Invernizzi Pietro, Palak J Trivedi, Lisa Forman, David E J Jones, Stephen D Ryder, Mark G Swain, Alexandra Steinberg, Pol F Boudes, Yun-Jung Choi, Charles A McWherter, null null
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. Hepatology (Baltimore, Md.) (2023)